{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:19:30Z","timestamp":1772165970386,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The prevalence of Human Papillomavirus (HPV) infection in the general population is widely known, however, there are still few studies related to this infection in minority groups, Thus, the objective is to analyze the frequency of human papillomavirus and associated factors in quilombola and gypsy women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cross-sectional research with 145 quilombola and gypsy women from Caxias, Maranh\u00e3o. Two Pap smear collections were performed and a questionnaire with 46 questions was applied between January, 2020 and March, 2021. Descriptive analysis and Odds Ratio with 95% confidence interval were performed. The research was approved by the ethics committee.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 09 cases of atypia. The frequency of human papillomavirus was 41.37%, with a higher risk in quilombolas 55 (91.70%). Multiple infections were prevalent (53%) with high-risk genotypes 21 (35%). Types 16 and 18 together accounted for 42.85% of cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The frequency of human papillomavirus infection was higher than those recorded in the Northeast and Brazil, and therefore type 16 predominated. Due to limitations, the virus lineages and sublineages were not evaluated. Quilombola women had a higher rate of infection than gypsies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-023-02239-w","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T09:04:09Z","timestamp":1680599049000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Frequency of human papilomavirus and associated factors in gypsy and quilombola women"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9362-8651","authenticated-orcid":false,"given":"Jos\u00e9","family":"de Ribamar Ross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4696-3518","authenticated-orcid":false,"given":"Nat\u00e1lia Pereira","family":"Marinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2075-5780","authenticated-orcid":false,"given":"Flavia Castello Branco","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8062-0338","authenticated-orcid":false,"given":"Elamary","family":"da Costa Fraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2783-362X","authenticated-orcid":false,"given":"Maria","family":"do Desterro Soares Brand\u00e3o Nascimen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4401-9446","authenticated-orcid":false,"given":"Marco Aur\u00e9lio Palazzi","family":"Saf\u00e1di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"issue":"08","key":"2239_CR1","doi-asserted-by":"publisher","first-page":"49900","DOI":"10.37118\/ijdr.22714.08.2021","volume":"11","author":"JR Ross","year":"2021","unstructured":"Ross JR, C\u00f4ra GR, Machado RA, Santos GRB, Almeida LMN, Lopes KFAL, et al. Precancer risk in black Quilombola women with minor cytological abnormalities and its relationship to vaginal microbiome. Int J Dev Res. 2021;11(08):49900\u20135. https:\/\/doi.org\/10.37118\/ijdr.22714.08.2021.","journal-title":"Int J Dev Res"},{"issue":"6","key":"2239_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2239_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.canep.2016.07.015","volume":"44","author":"R Murillo","year":"2016","unstructured":"Murillo R, Herrero R, Sierra MS, Forman D. Cervical cancer in Central and South America: Burden of disease and status of disease control. Cancer Epidemiol. 2016;44(1):121\u201330. https:\/\/doi.org\/10.1016\/j.canep.2016.07.015.","journal-title":"Cancer Epidemiol"},{"issue":"10","key":"2239_CR4","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/ijc.30901","volume":"141","author":"S Vaccarella","year":"2017","unstructured":"Vaccarella S, Laversanne M, Ferlay J, Bray F. Cervical cancer in Africa, Latin America and the Caribbean and Asia: Regional inequalities and changing trends. Int J Cancer. 2017;141(10):1997\u20132001. https:\/\/doi.org\/10.1002\/ijc.30901.","journal-title":"Int J Cancer"},{"key":"2239_CR5","volume-title":"Cancer","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Cancer. 2022. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer"},{"key":"2239_CR6","unstructured":"Cancer National Institute Jos\u00e9 Alencar Gomes da Silva. Estimative 2020: Incidence of cancer in Brazil. Rio de Janeiro. 2019. Available from: https:\/\/www.inca.gov.br\/sites\/ufu.sti.inca.local\/files\/\/media\/document\/\/estimativa-2020-incidencia-de-cancer-no-brasil.pdf."},{"issue":"5","key":"2239_CR7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):359\u201386. https:\/\/doi.org\/10.1002\/ijc.29210.","journal-title":"Int J Cancer"},{"issue":"10","key":"2239_CR8","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.22481\/odeere.v5i10.6938","volume":"5","author":"RN Pereira","year":"2020","unstructured":"Pereira RN, Mussi RFF. Access to and use of health services by the black quilombola population: a literature review. J Grad Prog Ethnic Relations Contemporaneity. 2020;5(10):2525\u20134715. https:\/\/doi.org\/10.22481\/odeere.v5i10.6938.","journal-title":"J Grad Prog Ethnic Relations Contemporaneity"},{"key":"2239_CR9","unstructured":"Brazil. Funda\u00e7\u00e3o Palmares. Quilombola Certification. Available at: https:\/\/www.palmares.gov.br\/?page_id=37551."},{"issue":"3","key":"2239_CR10","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.yexmp.2015.11.001","volume":"99","author":"FA Silveira","year":"2015","unstructured":"Silveira FA, Almeida G, Furtado YL, Cavalcante S, Silva KS, Maldonado P, et al. The association of HPV genotype with the regression, persistence or progression of low-grade squamous intraepithelial lesions. Exp Mol Pathol. 2015;99(3):702\u20136 Available from: https:\/\/scihub.se\/10.1016\/j.yexmp.2015.11.00111.","journal-title":"Exp Mol Pathol"},{"issue":"18","key":"2239_CR11","doi-asserted-by":"publisher","first-page":"8145","DOI":"10.7314\/APJCP.2015.16.18.8145","volume":"16","author":"M Nishimura","year":"2015","unstructured":"Nishimura M, Miyatake T, Nakashima A, Miyoshi A, Mimura M, Nagamatsu M, et al. Clinical Significance of Atypical Squamous Cells of Undetermined Significance among Patients Undergoing Cervical Conization. Asian Pac J Cancer Pre. 2015;16(18):8145\u20137. https:\/\/doi.org\/10.7314\/APJCP.2015.16.18.8145.","journal-title":"Asian Pac J Cancer Pre"},{"issue":"12","key":"2239_CR12","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/dc.23173","volume":"42","author":"S Lee","year":"2014","unstructured":"Lee S, Kim JW, Hong JH, Song JY, Lee JK, Kim IS, et al. Clinical significance of HPV DNA cotesting in Korean women with ASCUS or ASC-H. Diagn Cytopathol. 2014;42(12):1058\u201362 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24825374\/.","journal-title":"Diagn Cytopathol"},{"issue":"4","key":"2239_CR13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/ijc.31390","volume":"143","author":"OK Vintermyr","year":"2018","unstructured":"Vintermyr OK, Andersland MS, Bjorge T, Skar R, Iversen OE, Nyg\u00e5r DM, et al. Human papillomavirus type specific risk of progression and remission during long-term followup of equivocal and low-grade HPV-positive cervical smears. Int J Cancer. 2018;143(4):851\u201360. https:\/\/doi.org\/10.1002\/ijc.31390.","journal-title":"Int J Cancer"},{"key":"2239_CR14","unstructured":"Rezende MT. Comparison of cervical cytopathological exams in the municipality of Ouro Preto, MG, Brazil, submitted to external quality monitoring. Master's Dissertation. Federal University of Ouro Preto. 2017. Available from: https:\/\/www.repositorio.ufop.br\/handle\/123456789\/7924."},{"key":"2239_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13027-015-0011-3","volume":"10","author":"AA Ribeiro","year":"2015","unstructured":"Ribeiro AA, Costa MCA, Rosane RF. HPV infection and cervical neoplasia: associated risk factors. Infect Agent Cancer. 2015;10:16 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4524198\/.","journal-title":"Infect Agent Cancer"},{"issue":"6","key":"2239_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1590\/s0100-720320140005010","volume":"36","author":"LC Thuler","year":"2014","unstructured":"Thuler LC, Aguiar SS, Bergmann A. Determinants of late stage diagnosis of cervical cancer in Brazil. Rev Bras Ginecol Obstet. 2014;36(6):237\u201343. https:\/\/doi.org\/10.1590\/s0100-720320140005010.","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"1","key":"2239_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00192-014-2464-0","volume":"26","author":"MA Weber","year":"2015","unstructured":"Weber MA, Limpens J, Roovers JP. Assessment of vaginal atrophy: a review. Int Urogynecol J. 2015;26(1):15\u201328 Dispon\u00edvel em: https:\/\/pubmed.ncbi.nlm.nih.gov\/25047897\/.","journal-title":"Int Urogynecol J"},{"issue":"2","key":"2239_CR18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.5935\/1676-2444,20190016","volume":"55","author":"LT Backes","year":"2019","unstructured":"Backes LT, Mezzomo LC, Buffon A, Calil LN. Cytomorphological analysis of cervical cytological smears of women aged over 60 years. J Braz Pat Med Lab. 2019;55(2):136\u201347. https:\/\/doi.org\/10.5935\/1676-2444,20190016.","journal-title":"J Braz Pat Med Lab"},{"issue":"6","key":"2239_CR19","doi-asserted-by":"publisher","first-page":"e0219173","DOI":"10.1371\/journal.pone.0219173","volume":"14","author":"S Ghosh","year":"2019","unstructured":"Ghosh S, Shetty RS, Pattanshetty SM, Mallya SD, Pandey D, Kabekkodu SP, et al. Human papilloma and other DNA virus infections of the cervix: A population based comparative research among tribal and general population in India. PLoS ONE. 2019;14(6):e0219173. https:\/\/doi.org\/10.1371\/journal.pone.0219173.","journal-title":"PLoS ONE"},{"issue":"2","key":"2239_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/CEJ.0000000000000522","volume":"29","author":"O \u015euteu","year":"2020","unstructured":"\u015euteu O, Blaga ML, Nyg\u00e5rd M, Leinonen MK, Nicula F, P\u0103i\u015f R, et al. Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania. Eur J Cancer Prev. 2020;29(2):141\u20138. https:\/\/doi.org\/10.1097\/CEJ.0000000000000522.","journal-title":"Eur J Cancer Prev"},{"issue":"4","key":"2239_CR21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3390\/vaccines10040579","volume":"10","author":"G Bogani","year":"2022","unstructured":"Bogani G, Lalli L, Sopracordevole F, Ciavattini A, Ghelardi A, Simoncini T, Plotti F, et al. Development of a Nomogram Predicting the Risk of Persistence\/Recurrence of Cervical Dysplasia. Vaccines (Basel). 2022;10(4):579. https:\/\/doi.org\/10.3390\/vaccines10040579.","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"2239_CR22","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1158\/1055-9965.EPI-12-1406","volume":"22","author":"M Schiffman","year":"2013","unstructured":"Schiffman M, Wentzensen N. Human papillomavirus (HPV) infection and the multi-stage carcinogenesis of cervical cancer. Cancer Epidemiol Biomarkers Prev. 2013;22(4):553\u201360. https:\/\/doi.org\/10.1158\/1055-9965.EPI-12-1406.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2239_CR23","first-page":"100186","volume":"8","author":"AT Lorenzi","year":"2019","unstructured":"Lorenzi AT, Fregnani JH, Villa LL, Sichero L, Nunes LFA. Diversity of human papillomavirus typing among the population of women living in rural and remote areas of the Brazilian territory. Papilomav\u00edrus Rsearth. 2019;8:100186 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31539646\/.","journal-title":"Papilomav\u00edrus Rsearth"},{"issue":"1","key":"2239_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-017-0499-3","volume":"18","author":"MDDSB Nascimento","year":"2018","unstructured":"Nascimento MDDSB, Vidal FCB, Silva MACND, Batista JE, Barbosa MDCL, Muniz Filho WE, et al. Prevalence of human papillomavirus infection among women from quilombo communities in northeastern Brazil. BMC Womens Heal. 2018;18(1):1\u201310. https:\/\/doi.org\/10.1186\/s12905-017-0499-3.","journal-title":"BMC Womens Heal"},{"issue":"5","key":"2239_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000214919","volume":"12","author":"RD Burk","year":"2009","unstructured":"Burk RD, Chen Z, Van Doorslaer K. Human Papillomaviruses: Genetic Basis of Carcinogenicity. Pub Health Genom. 2009;12(5):281\u201390. https:\/\/doi.org\/10.1159\/000214919.","journal-title":"Pub Health Genom"},{"issue":"3","key":"2239_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.7883\/yoken.JJID.2014.584","volume":"68","author":"I Kukimoto","year":"2015","unstructured":"Kukimoto I, Muramatsu M. Genetic Variations of Human Papillomavirus Type 16: Implications for Cervical Carcinogenesis. Jap J Infect Diseases. 2015;68(3):169\u201375. https:\/\/doi.org\/10.7883\/yoken.JJID.2014.584.","journal-title":"Jap J Infect Diseases"},{"key":"2239_CR27","doi-asserted-by":"publisher","first-page":"14453","DOI":"10.1073\/pnas.0606512103","volume":"103","author":"E Jager","year":"2006","unstructured":"Jager E, Karbach J, Gnjatic S, Neumann A, Bender A, Valmori D, et al. Recombinant vaccinia\/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients. Proc Natl Acad Sci. 2006;103:14453\u20138 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16984998\/.","journal-title":"Proc Natl Acad Sci"},{"key":"2239_CR28","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.1200\/JCO.2009.22.3883","volume":"27","author":"PT Kaumaya","year":"2009","unstructured":"Kaumaya PT, Foy KC, Garrett J, Rawale SV, Vicari D, Thurmond JM, et al. Phase I active immunotherapy with combination of two chimeric, humanepidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and\/or recurrent solid tumors. J Clin Oncol. 2009;27:5270\u20137 (https:\/\/pubmed.ncbi.nlm.nih.gov\/19752336\/).","journal-title":"J Clin Oncol"},{"key":"2239_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.critrevonc.2018.05.011","volume":"128","author":"CD Tucci","year":"2018","unstructured":"Tucci CD, Schiavi MC, Faiano P, D\u2019oria O, Prata G, Sciuga V, et al. Therapeutic vaccines and immune checkpoints inhibition options for gynecological cancers. Critical Reviews in Oncology \/ Hematology. 2018;128:30\u201342. https:\/\/doi.org\/10.1016\/j.critrevonc.2018.05.011.","journal-title":"Critical Reviews in Oncology \/ Hematology"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02239-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02239-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02239-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T09:10:15Z","timestamp":1680599415000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02239-w"}},"subtitle":["Human papillomavirus in gypsy and quilombola women"],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2239"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02239-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1771514\/v1","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,4]]},"assertion":[{"value":"18 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There was informed consent from all subjects and\/or their legal guardians. And all experimental protocols were approved by Research Ethics Committee by Maranh\u00e3o State University (Approval Number CAAE 96368518.4.0000.5554). All experiments were carried out in accordance with the relevant guidelines and regulations of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}